Notably, in the APP/PS1 transgenic mouse model of AD, metformin-induced activation of chaperone-mediated autophagy (CMA) substantially attenuates amyloid-β plaque deposition in the brain. This evidence concerns the gene PSEN1 and Alzheimer disease.